Benjamin F. Edwards & Company, Inc. Edwards Lifesciences Corp Transaction History

Benjamin F. Edwards & Company, Inc.

$5.51 Billion
Q1 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 10,246 shares of EW stock, worth $933,205. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,246

Previous 7,682 33.38%

Holding current value

$933,205

Previous $586,000 67.06%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$72.54 - $95.56 $185,992 - $245,015	2,564 Added 33.38%	10,246 $979,000
Q4 2023 Feb 06, 2024	BUY	$61.71 - $77.76 $107,313 - $135,224	1,739 Added 29.26%	7,682 $586,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $24,109 - $32,496	348 Added 6.22%	5,943 $412,000
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $2,849 - $3,301	35 Added 0.63%	5,595 $527,000
Q1 2023 Apr 27, 2023	SELL	$74.26 - $84.51 $2,302 - $2,619	-31 Reduced 0.55%	5,560 $460,000

Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $10,313 - $13,203	-151 Reduced 2.63%	5,591 $417,000
Q3 2022 Oct 28, 2022	SELL	$82.37 - $107.29 $6,919 - $9,012	-84 Reduced 1.44%	5,742 $474,000
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $9,774 - $14,494	-113 Reduced 1.9%	5,826 $554,000
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $75,042 - $94,458	-736 Reduced 11.03%	5,939 $699,000
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $3,191 - $3,920	30 Added 0.45%	6,675 $865,000
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $5,035 - $5,802	64 Added 0.97%	6,645 $556,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $9,319 - $11,859	-130 Reduced 1.94%	6,581 $600,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $1,209 - $1,573	18 Added 0.27%	6,711 $536,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $256,743 - $343,350	4,462 Added 200.0%	6,693 $463,000
Q1 2020 May 07, 2020	SELL	$52.41 - $81.0 $943 - $1,458	-18 Reduced 0.8%	2,231 $421,000
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $3,943 - $4,514	-55 Reduced 2.39%	2,249 $525,000
Q3 2019 Nov 05, 2019	SELL	$61.55 - $75.43 $4,800 - $5,883	-78 Reduced 3.27%	2,304 $507,000
Q2 2019 Aug 08, 2019	SELL	$55.74 - $64.41 $780 - $901	-14 Reduced 0.58%	2,382 $440,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $3,064 - $4,099	64 Added 2.74%	2,396 $458,000
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $3,573 - $4,384	-77 Reduced 3.2%	2,332 $357,000
Q2 2018 Jul 19, 2018	BUY	$42.45 - $51.3 $84,051 - $101,574	1,980 Added 461.54%	2,409 $351,000
Q4 2017 Jan 17, 2018	SELL	$33.79 - $39.39 $5,575 - $6,499	-165 Reduced 27.78%	429 $48,000
Q3 2017 Oct 24, 2017	BUY	$36.29 - $38.83 $21,556 - $23,065	594	594 $65,000

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Edwards Lifesciences Corp Transaction History